Atlas Trials

A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

Clinical trial NCT01965496 · COMPLETED

Trial details

NCT number
NCT01965496
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2012-03-01
Primary completion
2013-03-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.